Are you looking for an excuse to show off your socks? Join the conversation by tagging #Socks4Docs and tweeting photos of your vibrant socks to support the well-being of health professionals.

Today is #Socks4Docs Day; raising awareness of mental health issues amongst health care professionals.

Introducing my socks for #Socks4Docs Day! Raising awareness for health professionals’ mental health and wellbeing. If you see a colleague wearing bright socks today, remember to ask “How are you?”. #CrazySock4Docs Brigham and Women's Hospital Mass General MDs MassGeneral News

#Socks4Docs Day, Let’s raise the conversation on the health of all Health Care Professionals. #CrazySocks4Docs #AANAdvocacy #AANPALF Cape Cod Healthcare James Hillis American Academy of Neurology @AANPublic

#MGH providers show off their support for #CrazySocks4Docs today to raise awareness and start conversations about health professionals' well-being. #MentalHealthAwareness #physicianwellness MassGeneral News

So much respect for Julia Loewenthal, MD. Handling it like a boss as she always does!

When you spend some clinics with your residency director and he clearly knows what day is approaching! #Socks4Docs / #CrazySocks4Docs Day is happening this Friday - an international awareness day for health professionals’ wellbeing. Brigham and Women's Hospital Mass General MDs American Academy of Neurology

There shouldn’t be any shame for health professionals to admit they’re having a bad day (or week or month or year). I’ve done so before and will no doubt do so again. Here are my socks for this year. #Socks4Docs #CrazySocks4Docs #MH4Docs

Today’s challenge: make it through a Zoom meeting without someone asking “So where the bloody hell are you?”. #SocialDistancing #COVID19

Today is #Socks4Docs Day. A day of mental health awareness for health professionals. I purchased these socks when I was home for Christmas with the thought that they would remind me of the qualities that home… instagram.com/p/CBDVrdZHNN3/…

Super exciting, Casey Albin, MD! And also exciting to know that all those neurology pearls that you taught me (often at 3am) will soon be in print for others to learn from!! MGH Neurology American Academy of Neurology Neurology Today

Excited to be part of this #RadAIchat! My name is James Hillis and I am the Director of Clinical Operations for the Digital CRO at Mass General Brigham Data Science Office (DSO). Our group’s work focuses on the validation of diagnostic AI algorithms ahead of regulatory clearance.

T1. Medical AI regulation allows the benefits and risks of AI devices to be carefully considered. It ensures only acceptable risks are taken as AI technology continues to push boundaries. #RadAIchat

T1. A challenge for medical AI regulations though is the pace at which technology is evolving. Even before the introduction of large language models, it was a challenge for them keep up with the pace. #RadAIchat

T2. Most radiology AI devices come through the US Food and Drug Administration de novo / 510(k) pathways as Class II devices. Further details about the 510(k) pathway are available at fda.gov/medical-device…. #RadAIchat

T3. A critical area for the FDA approach for Class II devices are the "lanes" that are essentially created by different regulations. They each are associated with a regulation number and have their own special controls that are created during the de novo process. #RadAIchat

T3. Computer-assisted triage devices are under regulation number 892.2080 where the Viz.ai LVO device was the de novo device. A special control requires “Results from performance testing that demonstrate that the device will provide effective triage”. #RadAIchat

T3. These lanes can also restrict devices. As an example, the 892.2080 regulation states that “the device does not mark, highlight, or direct users' attention to a specific location in the original image”. #RadAIchat

Thanks Dania Daye, MD PhD. Yes, there are key differences between the US and EU approaches to regulating radiology AI/ML devices. These differences also highlight some of the ways to optimize the regulatory approaches. #RadAIchat

T3. A group of us recently detailed many differences between the US and EU approaches (see the table below taken from nature.com/articles/s4174…). #RadAIchat